Skip to Main Content

In advance of an upcoming meeting on regional trade, the U.S. trade representative urged the Colombian government to overhaul various practices for making medicines available, a topic that has increasingly angered the U.S. pharmaceutical industry.

In a Feb. 14 letter, Robert Lighthizer wrote to the Colombian trade minister that “key stakeholders remain dissatisfied” with government policies. The letter was sent as a meeting nears this month, according to sources, to discuss membership in the Organization for Economic Cooperation and Development, an intergovernmental group of three dozen countries that was created to stimulate economic progress and world trade.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!